Preferred Label : Mosaic variegated aneuploidy syndrome 1;
Symbol : MVA1;
CISMeF acronym : MVA1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Mva syndrome;
Description : Mosaic variegated aneuploidy is an autosomal recessive disorder characterized by mosaic
aneuploidies, predominantly trisomies and monosomies, involving multiple different
chromosomes and tissues (Hanks et al., 2004). The proportion of aneuploid cells varies
but is usually more than 25% and is substantially greater than in normal individuals.
Affected individuals typically present with severe intrauterine growth retardation
and microcephaly. Eye anomalies, mild dysmorphism, variable developmental delay, and
a broad spectrum of additional congenital abnormalities and medical conditions may
also occur. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor, and
leukemia reported in several cases. See also MVA2 (614114), caused by mutation in
the CEP57 gene (607951) on chromosome 11q21.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the BUB1 mitotic checkpoint serine/threonine kinase B gene (BUB1B,
602860.0003);
Neoplasia : Propensity to tumor development; Wilms tumor; Nephroblastoma; Rhabdomyosarcoma; Leukemia;
Laboratory abnormalities : Mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy; More than 50% of mitotic cells show premature chromatid separation (PCS) affecting
all chromosomes; Anaphase loss or nondisjunction with trisomies, tetrasomies, monosomies;
Prefixed ID : #257300;
Origin ID : 257300;
UMLS CUI : C1850343;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)